Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Catharina Suharti
Longer Hydroxyurea Administration Prior to Imatinib Mesylate Is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role
Asian Pacific Journal of Cancer Prevention
Related publications
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica
Hematology
Cost Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Chronic Myeloid Leukemia
PLoS ONE
Multidisciplinary
Polycomb Genes Are Associated With Response to Imatinib in Chronic Myeloid Leukemia
Epigenomics
Cancer Research
Genetics
Somatic Mutations Identified at Diagnosis by Exome Sequencing Can Predict Response to Imatinib in Chronic Phase Chronic Myeloid Leukemia Patients
American Journal of Hematology
Hematology
Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
New Tool for Monitoring Molecular Response in Chronic Myeloid Leukemia.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
